247 related articles for article (PubMed ID: 31216997)
61. TOP2A induces malignant character of pancreatic cancer through activating β-catenin signaling pathway.
Pei YF; Yin XM; Liu XQ
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):197-207. PubMed ID: 29045811
[TBL] [Abstract][Full Text] [Related]
62. Identification of Immune-Related Subtypes and Construction of a Novel Prognostic Model for Bladder Urothelial Cancer.
Zhang J; Huang C; Yang R; Wang X; Fang B; Mi J; Yuan H; Mo Z; Sun Y
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421685
[TBL] [Abstract][Full Text] [Related]
63. Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.
Wang X; Bai Y; Zhang F; Li D; Chen K; Wu R; Tang Y; Wei X; Han P
Front Immunol; 2023; 14():955949. PubMed ID: 37006317
[TBL] [Abstract][Full Text] [Related]
64. Investigating cellular similarities and differences between upper tract urothelial carcinoma and bladder urothelial carcinoma using single-cell sequencing.
Zhang Q; Wang C; Qin M; Ye Y; Mo Y; Meng Q; Yang G; Feng G; Lin R; Xian S; Wei J; Chen S; Wang S; Mo Z
Front Immunol; 2024; 15():1298087. PubMed ID: 38903524
[TBL] [Abstract][Full Text] [Related]
65. Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB.
Xiong S; Li S; Zeng J; Nie J; Liu T; Liu X; Chen L; Fu B; Deng J; Xu S
Front Immunol; 2023; 14():1253586. PubMed ID: 37790935
[TBL] [Abstract][Full Text] [Related]
66. Mutual regulation of MDM4 and TOP2A in cancer cell proliferation.
Liu T; Zhang H; Yi S; Gu L; Zhou M
Mol Oncol; 2019 May; 13(5):1047-1058. PubMed ID: 30672125
[TBL] [Abstract][Full Text] [Related]
67. The oncogenic role of TFAP2A in bladder urothelial carcinoma via a novel long noncoding RNA TPRG1-AS1/DNMT3A/CRTAC1 axis.
He J; Dong C; Zhang H; Jiang Y; Liu T; Man X
Cell Signal; 2023 Feb; 102():110527. PubMed ID: 36410635
[TBL] [Abstract][Full Text] [Related]
68. Identification of a basement membrane-related genes signature with immune correlation in bladder urothelial carcinoma and verification in vitro.
Li Y; Xu K; Zhang Y; Mao H; Qiu Q; Yan Z; Liu X; Du Y; Chen Z
BMC Cancer; 2023 Oct; 23(1):1021. PubMed ID: 37872487
[TBL] [Abstract][Full Text] [Related]
69. Prognostic significance of TOP2A gene dosage in HER-2-negative breast cancer.
Zaczek AJ; Markiewicz A; Seroczynska B; Skokowski J; Jaskiewicz J; Pienkowski T; Olszewski WP; Szade J; Rhone P; Welnicka-Jaskiewicz M; Jassem J
Oncologist; 2012; 17(10):1246-55. PubMed ID: 22871798
[TBL] [Abstract][Full Text] [Related]
70. A novel signature constructed by mitochondrial function and cell death-related gene for the prediction of prognosis in bladder cancer.
Yan Z; Liu Y; Wang M; Wang L; Chen Z; Liu X
Sci Rep; 2024 Jun; 14(1):14667. PubMed ID: 38918587
[TBL] [Abstract][Full Text] [Related]
71. Overexpression of immunoglobulin G prompts cell proliferation and inhibits cell apoptosis in human urothelial carcinoma.
Liang PY; Li HY; Zhou ZY; Jin YX; Wang SX; Peng XH; Ou SJ
Tumour Biol; 2013 Jun; 34(3):1783-91. PubMed ID: 23483488
[TBL] [Abstract][Full Text] [Related]
72. Androgen dihydrotestosterone promotes bladder cancer cell proliferation and invasion via EPPK1-mediated MAPK/JUP signalling.
Yang L; Huang W; Bai X; Wang H; Wang X; Xiao H; Li Y
Cell Death Dis; 2023 Jun; 14(6):363. PubMed ID: 37328487
[TBL] [Abstract][Full Text] [Related]
73. Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials.
Fountzilas G; Dafni U; Bobos M; Kotoula V; Batistatou A; Xanthakis I; Papadimitriou C; Kostopoulos I; Koletsa T; Tsolaki E; Televantou D; Timotheadou E; Koutras A; Klouvas G; Samantas E; Pisanidis N; Karanikiotis C; Sfakianaki I; Pavlidis N; Gogas H; Linardou H; Kalogeras KT; Pectasides D; Dimopoulos MA
BMC Cancer; 2013 Mar; 13():163. PubMed ID: 23537287
[TBL] [Abstract][Full Text] [Related]
74. Gastrointestinal stromal tumors - quantitative detection of the Ki-67, TPX2, TOP2A, and hTERT telomerase subunit mRNA levels to determine proliferation activity and a potential for aggressive biological behavior.
Kalfusova A; Hilska I; Krskova L; Kalinova M; Linke Z; Kodet R
Neoplasma; 2016; 63(3):484-92. PubMed ID: 26952515
[TBL] [Abstract][Full Text] [Related]
75. Promoter methylation of DNA damage repair (DDR) genes in human tumor entities:
Mijnes J; Veeck J; Gaisa NT; Burghardt E; de Ruijter TC; Gostek S; Dahl E; Pfister D; Schmid SC; Knüchel R; Rose M
Clin Epigenetics; 2018; 10():15. PubMed ID: 29445424
[TBL] [Abstract][Full Text] [Related]
76. Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis.
Olivieri M; Ferro M; Terreri S; Durso M; Romanelli A; Avitabile C; De Cobelli O; Messere A; Bruzzese D; Vannini I; Marinelli L; Novellino E; Zhang W; Incoronato M; Ilardi G; Staibano S; Marra L; Franco R; Perdonà S; Terracciano D; Czerniak B; Liguori GL; Colonna V; Fabbri M; Febbraio F; Calin GA; Cimmino A
Oncotarget; 2016 Apr; 7(15):20636-54. PubMed ID: 26943042
[TBL] [Abstract][Full Text] [Related]
77. HER-2 and TOP2A coamplification in urinary bladder cancer.
Simon R; Atefy R; Wagner U; Forster T; Fijan A; Bruderer J; Wilber K; Mihatsch MJ; Gasser T; Sauter G
Int J Cancer; 2003 Dec; 107(5):764-72. PubMed ID: 14566826
[TBL] [Abstract][Full Text] [Related]
78. CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.
Xue Y; Wu G; Wang X; Zou X; Zhang G; Xiao R; Yuan Y; Long D; Yang J; Wu Y; Xu H; Liu F; Liu M
Med Oncol; 2013 Mar; 30(1):406. PubMed ID: 23275123
[TBL] [Abstract][Full Text] [Related]
79. Expression and Prognostic Values of the Roof Plate-Specific Spondin Family in Bladder Cancer.
Gao L; Meng J; Zhang M; Fan S; Gao S; Wang X; Liang C
DNA Cell Biol; 2020 Jun; 39(6):1072-1089. PubMed ID: 32352838
[TBL] [Abstract][Full Text] [Related]
80. Sp1 is overexpressed and associated with progression and poor prognosis in bladder urothelial carcinoma patients.
Zhu J; Lu Z; Ke M; Cai X
Int Urol Nephrol; 2022 Jul; 54(7):1505-1512. PubMed ID: 35467245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
